Figure 3. Plasma mean concentrations (ng/ml) after 500 mg oral dose of azithromycin susp to 28 healthy humans, and IVIVC Prediction profile

From

Physiologically-Based IVIVC of Azithromycin

Nasir M. Idkaidek, Naji Najib, Isam Salem, Jamal Jilani

American Journal of Pharmacological Sciences. 2014, 2(6), 100-102 doi:10.12691/ajps-2-6-1